Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
MRI, Targeted Biopsy, Intervention and Biomarkers in Prostate Cancer Management 2018: A Paradigm Shift in Detection, Grading, Staging, Reporting, Biopsy and Treatment
Activity Details
Activity Name: MRI, Targeted Biopsy, Intervention and Biomarkers in Prostate Cancer Management 2018: A Paradigm Shift in Detection, Grading, Staging, Reporting, Biopsy and Treatment
Needs Assessment:

Prostate cancer is the second most common solid organ malignancy diagnosed in men. Unlike other solid organ malignancies, the challenge in prostate cancer is to confidently identify men with moderate and high grade cancers who would benefit most from aggressive therapy and triage the rest to active surveillance. Uniquely among solid organ cancers, imaging has not been a traditional part of the workup for prostate cancer, which has relied instead on transrectal US-guided template biopsy. Over the past few years, MR imaging has emerged as the best imaging modality to detect, grade and stage prostate cancer and is considered a valuable biomarker. The course will focus on the evolving role of MR imaging in prostate cancer diagnosis, monitoring, targeted biopsy and in focal and whole gland therapy planning. We will review all relevant MR imaging components of prostate cancer, new molecular modalities such as PSMA PET and an update on prostate cancer biomarkers.

Target Audience:
Radiologists, urologists, radiation and medical oncologists and primary care physicians interested in understanding prostate MR imaging and its applications for active surveillance, biopsy planning and acquisition, surgical planning and radiation planning and its role as a prostate biomarker

Course Objectives:

At the conclusion of this course, participants should be better able to:

  • Understand state-of-the art prostate MR imaging, biomarkers and artificial intelligence
  • Integrate prostate MR imaging into active surveillance and targeted biopsy planning
  • Incorporate prostate MR imaging into robotic prostatectomy and radiation planning
  • Illustrate the role for molecular imaging of prostate cancer: PSMA, Axumin and Choline PET
  • Evaluate the risks and benefits of focal and whole gland therapies
Location Information
Meeting Location: UCLA Meyer & Renee Luskin Conference Center
Location Address: 425 Westwood Plaza
Location City: Los Angeles
Location State: CA
Location Postal Code: 90095
Location Country: US
Activity Information
Start Date: 2/17/2018
End Date: 2/17/2018
Fees:
  • $275 - MD Early Bird (by January 28, 2018)
  • $325 - MD (beginning January 29, 2018)
  • Fellows/Residents/Techs/Nurses $200
Meeting URL: https://www.cme.ucla.edu/courses/event-description?registration_id=214485
Printable Materials: https://www.cme.ucla.edu/courses/cme-download?registration_id=214485
Credit Information
Credit Amount: 8
Credit Unit: Credits
Accreditation: ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
Activity Learning Format: Live Activity
Accreditor/Sponsor
Sponsor Name: David Geffen School of Medicine at UCLA Office of Continuing Medical Education
Sponsor Address: 10920 Wilshire Blvd., Suite 1060
Sponsor City: Los Angeles
Sponsor State: CA
Sponsor Postal Code: 90024
Sponsor Country: US
Contact Information
Contact Name: Eloisa Ayala
Contact Address: 10920 Wilshire Blvd., Suite 1060
Contact City: Los Angeles
Contact State: CA
Contact Postal Code: 90024
Contact Country: US
Contact Phone: 310-794-2620
Contact Email: eayala@mednet.ucla.edu

Type:     Live Activity
0 Registered Users